InvestorsHub Logo
Followers 12
Posts 1102
Boards Moderated 0
Alias Born 01/27/2017

Re: None

Tuesday, 02/25/2020 6:47:44 AM

Tuesday, February 25, 2020 6:47:44 AM

Post# of 203913
It's quite unbelievable how much slack Dr. Hirsch has been given since his arrival in July 2017. For the record, it was not just his plan to take the company in a different direction as far as the psoriasis cream is concerned. An "undifferentiated"path is another way of buying more time and muddying the waters, but it was months earlier when in an 8-K the company stated:

OWC Pharmaceutical Research Corp. ("OWC") is reporting the issuance on April 5, 2017 of the attached press release, announcing that as a result of the promising conclusions reported in its Form 8-K filed on March 20, 2017, the Company has received expressions of scientific and medical interest, world-wide, for its cannabinoid-based topical cream for treating psoriasis. OWC has expanded the size and scope of its clinical studies and, as previously announced, anticipates that subject to pending regulatory approvals from applicable jurisdictions, the topical cream should be available for use by those who suffer from psoriasis in the near term.


When I read the words "expanded the size and scope of its clinical studies" I immediately felt that they were just stringing us along for a much longer ride. At some point even a PHD student has to get a job before potentially having to declare bankruptcy.

Anyway getting back to Dr. Hirsch, what has he done exactly since his arrival? Zzzzzzz...crickets...zzzzzzz...crickets...zzzzzzzz